(Q31975938)

5 July 2017

1 reference

title

Misoprostol therapeutics revisited (English)

1 reference

5 July 2017

1 reference

Davies NM

1

1 reference

5 July 2017

Longstreth J

series ordinal

2

1 reference

5 July 2017

Jamali F

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

21

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

60-73

1 reference

Low-dose mifepristone 200 mg and vaginal misoprostol for abortion

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Methotrexate and misoprostol for early abortion in adolescent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol preclinical pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Tumor necrosis factor and alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Contrasting effects of misoprostol on systemic and intrapulmonary lipopolysaccharide-induced tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

The prostaglandin analogs, misoprostol and SC-46275, potently inhibit cytokine release from activated human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effects of food and antacid on oral absorption of misoprostol, a synthetic prostaglandin E1 analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol does not alter the pharmacokinetics of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Prostanoid receptors involved in the relaxation of human bronchial preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

The effects of E series prostaglandins on blastogenic responses in vitro and graft vs. host responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effects of misoprostol on human circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effect of misoprostol on concentrations of prostaglandins in synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Synthetic prostaglandin E1 misoprostol as a treatment for tinnitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effect of misoprostol on fat malabsorption in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Evaluation of the renal protective effect of misoprostol in elderly, osteoarthritic patients at risk for nonsteroidal anti-inflammatory drug-induced renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Minimization of indomethacin-induced reduction in renal function by misoprostol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Prostaglandins and the treatment of hepatorenal syndrome in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol associated autonomic dysreflexia in a traumatic tetraplegic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Functional and morphological alterations following irradiation of isolated rat stomach: a model for estimation of radiation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Role of prostaglandins in the early phases of experimental gastric carcinogenesis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

High prevalence of NSAID enteropathy as shown by a simple faecal test

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Life-threatening diarrhea after short-term misoprostol use in a patient with Crohn ileocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Diarrhea after misoprostol in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Microvascular changes in liver after ischemia-reperfusion injury. Protection with misoprostol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Novel applications of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

One year follow-up of patients treated with misoprostol in acute phase of viral hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Oral misoprostol for third stage of labor: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Radioprotective effects of prostaglandins for chromosomal aberrations and cell killing in V79 Chinese hamster cells grown as spheroids in vitro and for mouse spermatogonial stem cells and bone marrow cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol-induced radioprotection of oncogenic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Gastric mucosal damage in sepsis--effects of pretreatment with a synthetic prostaglandin E1 analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Radioprotective effect of misoprostol on mouse spermatogonial stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Differential radioprotective effects of misoprostol in DNA repaircell proficient and-deficient or radiosensitive systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Duodenal pH in cystic fibrosis and its relationship to fat malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

Misoprostol therapy following trinitrobenzene sulfonic acid-induced colitis accelerates healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.1.60.34442

10.1592/PHCO.21.1.60.34442

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference